Bella Pharmaceuticals is recalling 3,407 units of various sterile injectable medications and ophthalmic (eye) products, including Glutathione, Methylcobalamin, and Bevacizumab, due to concerns that they may not be sterile. The recall was initiated after a lack of assurance of sterility was identified, which could lead to serious infections in patients receiving these injections. These products were distributed nationwide in the United States between July and August 2017. Consumers should immediately stop using any remaining products from the affected lots and consult with their healthcare provider.
If an injectable or eye medication is not sterile, it can introduce bacteria or other microorganisms directly into the body or the eye, potentially causing life-threatening infections, permanent vision loss, or other severe health complications.
Full refund upon return of unused product.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.